US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Horizon Therapeutics Public Limited Company (HZNP)
Horizon Therapeutics Public Limited Company (HZNP) ニュース

HZNP

Horizon Therapeutics Pub... (HZNP)

Horizon Therapeutics Public Limited Company

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HZNP

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/10/17	05 : 44	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/09	20 : 33	IH Market News	Monday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and more	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	07 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	07 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	07 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	07 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	06 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	06 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	06 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 30	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 28	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 26	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 24	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 22	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 20	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 18	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 16	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 13	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 11	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 08	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/07	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/06	21 : 30	Business Wire	Rule 17(e) Announcement - Horizon Therapeutics plc	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/05	20 : 40	Business Wire	Rule 17(d) Announcement – Horizon Therapeutics plc	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/05	20 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/04	00 : 15	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/04	00 : 06	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/03	00 : 39	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/03	00 : 24	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
2023/10/02	21 : 00	Business Wire	Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company

Showing the most relevant articles for your search:NASDAQ:HZNP

1 2 3 4 5 6 7 8 9 10 次へ >>

Health Care Select Sector

Energy Select Sector SPDR

JP Morgan Chase

Deutsche Telekom (QX)

Verizon Communications

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約